Literature DB >> 25904703

Hyperglycemia in the absence of cilia accelerates cystogenesis and induces renal damage.

Kelli M Sas1, Hong Yin2, Wayne R Fitzgibbon3, Catalin F Baicu4, Michael R Zile5, Stacy L Steele6, May Amria3, Takamitsu Saigusa3, Jason Funk3, Marlene A Bunni3, Gene P Siegal7, Brian J Siroky2, John J Bissler2, P Darwin Bell6.   

Abstract

In polycystic kidney disease (PKD), the rate of cyst formation and disease progression is highly variable. The lack of predictability in disease progression may be due to additional environmental factors or pathophysiological processes called "third hits." Diabetes is a growing epidemic, and recent studies suggest that PKD patients may be at an increased risk for this disease. We sought to determine if hyperglycemia enhances the initiation and rate of cystogenesis. Tamoxifen was administered to adult Ift88 conditional floxed allele mice to induce cilia loss in the presence of Cre. Subsequent administration of streptozotocin resulted in equivalent hyperglycemia in cilia(+) and cilia(-) mice. Hyperglycemia with loss of cilia increased the rate of cyst formation and cell proliferation. Structural and functional alterations in the kidney, including focal glomerular foot process effacement, interstitial inflammation, formation of primitive renal tubules, polyuria, and increased proteinuria, were also observed in hyperglycemic cilia(-) mice. Gene array analysis indicated enhanced Wnt and epithelial-to-mesenchymal transition signaling in the kidney of hyperglycemic cilia(-) mice. These data show that hyperglycemia, in the absence of cilia, results in renal structural and functional damage and accelerates cystogenesis, suggesting that diabetes is a risk factor in the progression of PKD.

Entities:  

Keywords:  Wnt; diabetes; epithelial-to-mesenchymal transition; polycystic kidney disease; streptozotocin

Mesh:

Substances:

Year:  2015        PMID: 25904703      PMCID: PMC4490377          DOI: 10.1152/ajprenal.00652.2014

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  39 in total

1.  Transition of kidney tubule cells to a senescent phenotype in early experimental diabetes.

Authors:  Joseph Satriano; Hadi Mansoury; Aihua Deng; Kumar Sharma; Volker Vallon; Roland C Blantz; Scott C Thomson
Journal:  Am J Physiol Cell Physiol       Date:  2010-05-26       Impact factor: 4.249

2.  Loss of primary cilia upregulates renal hypertrophic signaling and promotes cystogenesis.

Authors:  P Darwin Bell; Wayne Fitzgibbon; Kelli Sas; Antine E Stenbit; May Amria; Amber Houston; Ryan Reichert; Sandra Gilley; Gene P Siegal; John Bissler; Mehmet Bilgen; Peter Cheng-te Chou; Lisa Guay-Woodford; Brad Yoder; Courtney J Haycraft; Brian Siroky
Journal:  J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 10.121

3.  Third-hit signaling in renal cyst formation.

Authors:  Thomas Weimbs
Journal:  J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 10.121

4.  Epithelial-to-mesenchymal transition in cyst lining epithelial cells in an orthologous PCK rat model of autosomal-recessive polycystic kidney disease.

Authors:  Hiroko Togawa; Koichi Nakanishi; Hironobu Mukaiyama; Taketsugu Hama; Yuko Shima; Mayumi Sako; Masayasu Miyajima; Kandai Nozu; Kazuhiro Nishii; Shizuko Nagao; Hisahide Takahashi; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Am J Physiol Renal Physiol       Date:  2010-11-17

5.  Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia/reperfusion.

Authors:  Ana P Bastos; Klaus Piontek; Ana M Silva; Dino Martini; Luis F Menezes; Jonathan M Fonseca; Ivone I Fonseca; Gregory G Germino; Luiz F Onuchic
Journal:  J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 10.121

6.  Metabolic syndrome components in patients with autosomal-dominant polycystic kidney disease.

Authors:  Maria Pietrzak-Nowacka; Krzysztof Safranow; Elzbieta Byra; Agnieszka Bińczak-Kuleta; Andrzej Ciechanowicz; Kazimierz Ciechanowski
Journal:  Kidney Blood Press Res       Date:  2009-11-20       Impact factor: 2.687

7.  Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways.

Authors:  Hester Happé; Wouter N Leonhard; Annemieke van der Wal; Bob van de Water; Irma S Lantinga-van Leeuwen; Martijn H Breuning; Emile de Heer; Dorien J M Peters
Journal:  Hum Mol Genet       Date:  2009-04-28       Impact factor: 6.150

Review 8.  Mouse models of diabetic nephropathy.

Authors:  Frank C Brosius; Charles E Alpers; Erwin P Bottinger; Matthew D Breyer; Thomas M Coffman; Susan B Gurley; Raymond C Harris; Masao Kakoki; Matthias Kretzler; Edward H Leiter; Moshe Levi; Richard A McIndoe; Kumar Sharma; Oliver Smithies; Katalin Susztak; Nobuyuki Takahashi; Takamune Takahashi
Journal:  J Am Soc Nephrol       Date:  2009-09-03       Impact factor: 10.121

Review 9.  Cystic kidney disease: the role of Wnt signaling.

Authors:  Madeline A Lancaster; Joseph G Gleeson
Journal:  Trends Mol Med       Date:  2010-06-22       Impact factor: 11.951

10.  Primary cilia are not required for normal canonical Wnt signaling in the mouse embryo.

Authors:  Polloneal Jymmiel R Ocbina; Miquel Tuson; Kathryn V Anderson
Journal:  PLoS One       Date:  2009-08-31       Impact factor: 3.240

View more
  12 in total

1.  Environmental hit on a genetic basis in polycystic kidney disease.

Authors:  Shixuan Wang; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2016-08-24

2.  Suppressing angiotensinogen synthesis attenuates kidney cyst formation in a Pkd1 mouse model.

Authors:  Takamitsu Saigusa; Yujing Dang; Adam E Mullick; Steve T Yeh; Michael R Zile; Catalin F Baicu; P Darwin Bell
Journal:  FASEB J       Date:  2015-09-21       Impact factor: 5.191

3.  Ketosis Ameliorates Renal Cyst Growth in Polycystic Kidney Disease.

Authors:  Jacob A Torres; Samantha L Kruger; Caroline Broderick; Tselmeg Amarlkhagva; Shagun Agrawal; John R Dodam; Michal Mrug; Leslie A Lyons; Thomas Weimbs
Journal:  Cell Metab       Date:  2019-10-17       Impact factor: 27.287

4.  Metabolic reprogramming in a slowly developing orthologous model of polycystic kidney disease.

Authors:  Katharina Hopp; Emily K Kleczko; Berenice Y Gitomer; Michel Chonchol; Jost Klawitter; Uwe Christians; Jelena Klawitter
Journal:  Am J Physiol Renal Physiol       Date:  2022-01-17

5.  Glucose promotes secretion-dependent renal cyst growth.

Authors:  Andre Kraus; Gunnar Schley; Karl Kunzelmann; Rainer Schreiber; Dorien J M Peters; Ruth Stadler; Kai-Uwe Eckardt; Bjoern Buchholz
Journal:  J Mol Med (Berl)       Date:  2015-09-03       Impact factor: 4.599

Review 6.  Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Evidence and Therapeutic Potential.

Authors:  Kristen L Nowak; Katharina Hopp
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-21       Impact factor: 8.237

7.  Attenuation of accelerated renal cystogenesis in Pkd1 mice by renin-angiotensin system blockade.

Authors:  Wayne R Fitzgibbon; Yujing Dang; Marlene A Bunni; Catalin F Baicu; Michael R Zile; Adam E Mullick; Takamitsu Saigusa
Journal:  Am J Physiol Renal Physiol       Date:  2017-10-11

8.  Truncating PKHD1 and PKD2 mutations alter energy metabolism.

Authors:  Phillip Chumley; Juling Zhou; Sylvie Mrug; Balu Chacko; John M Parant; Anil K Challa; Landon S Wilson; Taylor F Berryhill; Stephen Barnes; Robert A Kesterson; P Darwin Bell; Victor M Darley-Usmar; Bradley K Yoder; Michal Mrug
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-19

9.  Targeted Next-Generation Sequencing Identifies Pathogenic Variants in Diabetic Kidney Disease.

Authors:  Jose Lazaro-Guevara; Julio Fierro-Morales; A Hunter Wright; River Gunville; Christopher Simeone; Scott G Frodsham; Melissa H Pezzolesi; Courtney A Zaffino; Laith Al-Rabadi; Nirupama Ramkumar; Marcus G Pezzolesi
Journal:  Am J Nephrol       Date:  2021-03-26       Impact factor: 3.754

10.  Interferon Regulatory Factor-5 in Resident Macrophage Promotes Polycystic Kidney Disease.

Authors:  Kurt A Zimmerman; Jifeng Huang; Lan He; Dustin Z Revell; Zhang Li; Jung-Shan Hsu; Wayne R Fitzgibbon; E Starr Hazard; Gary Hardiman; Michal Mrug; P Darwin Bell; Bradley K Yoder; Takamitsu Saigusa
Journal:  Kidney360       Date:  2020-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.